Literature DB >> 9232702

Timing of free microsurgical tissue transfer for the acute phase of hand injuries.

P Brenner1, F Lassner, M Becker, A Berger.   

Abstract

Because of favourable survival rates in replantation surgery and a high standard of free tissue transfer the interval between injury and microsurgical reconstruction has become gradually shorter. The acute phase can be defined as the interval ranging from emergency procedures within 24 hours to urgent procedures done within 72 hours. Bearing in mind the infection rates that have been reported of 1.5% for the acute phase and 17.5% for the late phase, we should encourage emergency reconstructions. However, in most cases of upper extremity injuries, reconstruction with conventional flaps is possible. Between 1981 and 1995 we did 72 acute post-traumatic free tissue transfers to the upper extremity in our unit within 72 hours (urgently). There were no significant differences in the incidence of infections when acute were compared with urgent procedures. As a result we support the concept of urgent operations. The following advantages are to be considered: urgent operations allow a second look operation, the viability of the extremity can be assessed, and the reconstructive procedure can be planned more precisely. Last but not least, the procedure is done during the day time with better operating conditions.

Entities:  

Mesh:

Year:  1997        PMID: 9232702     DOI: 10.3109/02844319709085484

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  2 in total

1.  The reconstruction of the mutilated hand.

Authors:  Michael Neumeister; Thersa Hegge; Ashley Amalfi; Michael Sauerbier
Journal:  Semin Plast Surg       Date:  2010-02       Impact factor: 2.314

2.  Neo-digit functional reconstruction of mutilating hand injury using transplantation of multiple composite tissue flaps.

Authors:  Xiucun Li; Jianli Cui; Suraj Maharjan; Xin Yu; Laijin Lu; Xu Gong
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.